CytoDyn (CYDY) Current Assets (2011 - 2026)
CytoDyn (CYDY) recorded Current Assets of $13.88 million in fiscal Q4 2026 (quarter ended May 31, 2026), down 22.4% from $17.88 million a year earlier and down 24.7% from the prior quarter.
CytoDyn (CYDY) Current Assets (2011 - 2026) Analysis & Trends
Starting with fiscal Q4 2011, CytoDyn's Current Assets history includes 61 quarters.
- Annual Current Assets has a five-year compound annual growth rate of -17.4% (FY2021 to FY2026).
- Across earlier fiscal years, Current Assets came in at $17.88 million in FY2025 (+65.3%), $10.82 million in FY2024 (+0.1%), $10.81 million in FY2023 (+2.8%) and $10.52 million in FY2022 (-70.9%).
- Quarterly Current Assets has ranged from $6.55 million in fiscal Q2 2023 to $102.79 million in fiscal Q1 2022 over the past five years.
- On a year-over-year basis, Current Assets has declined for four consecutive quarters, with growth averaging 42.1% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 178.7% in fiscal Q2 2025, against a decline of 93.6% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $18.44 million (Q3 2026), $8.84 million (Q2 2026) and $13.35 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | CytoDyn | 288.44 Mn | 288.44 Mn | - | 13.88 Mn |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 13.88 Mn |
| Feb 28, 2026 | 18.44 Mn |
| Nov 30, 2025 | 8.84 Mn |
| Aug 31, 2025 | 13.35 Mn |
| May 31, 2025 | 17.88 Mn |
| Feb 28, 2025 | 20.98 Mn |
| Nov 30, 2024 | 24.63 Mn |
| Aug 31, 2024 | 27.74 Mn |
| May 31, 2024 | 10.82 Mn |
| Feb 29, 2024 | 9.91 Mn |
| Nov 30, 2023 | 8.84 Mn |
| Aug 31, 2023 | 11.97 Mn |
| May 31, 2023 | 10.81 Mn |
| Feb 28, 2023 | 14.11 Mn |
| Nov 30, 2022 | 6.55 Mn |
| Aug 31, 2022 | 9.86 Mn |
| May 31, 2022 | 10.52 Mn |
| Feb 28, 2022 | 92.35 Mn |
| Nov 30, 2021 | 101.81 Mn |
| Aug 31, 2021 | 102.79 Mn |
CytoDyn Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();